Houlihan Lokey, Inc. HLI | NYSE

$166.74 $2.84 | 1.73%

Next Earnings: May 07, 2025

Company Overview:

Market Cap: $11.70B
PE Ratio: 31.88
52-Week Range: $127.14 - $192.10
Dividend Yield (FWD): 1.39% ($2.28)

6.3 Year Performance Metrics:

Total Return (with DRIP): 322.32% (25.69% / yr)
Total Return (no DRIP): 295.64% (24.40% / yr)
Share Price: 270.48%
Dividend Increase: 111.11
HLI 6.3-yr Total Return ($10K invested)
1Y 2Y 5Y 10Y All

HLI Dividend Payments, Yield & Share Price charts

Dividend Payments & Yield
HLI Dividend CAGR:1Y: 3.64%2Y: 3.70%5Y: 12.95%10Y: N/A
Share Price
HLI Price CAGR:1Y: 28.71%2Y: 34.21%5Y: 23.28%10Y: 13.99%

Unlock All Reports & Research Dividend Stocks like a BOSS!

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 25% OFF
$135/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial

HLI Dividend Safety: Payout & Dividend to Free Cash Flow Ratios.

Dividend Payout Ratio - HLI
14-Day FREE Trial Get Full Access Now!
Dividend to Free Cash Flow Ratio - HLI
14-Day FREE Trial Get Full Access Now!

HLI Earnings, Revenue, Cash & Debt, Shares Outstaning:

HLI - EPS vs PE Ratio
14-Day FREE Trial Get Full Access Now!
HLI - FCF vs FCF / Share
14-Day FREE Trial Get Full Access Now!
HLI - EPS vs FCF / Share
14-Day FREE Trial Get Full Access Now!
HLI - FCF vs Stock Based Comp
14-Day FREE Trial Get Full Access Now!
HLI - Revenue vs Net Income
14-Day FREE Trial Get Full Access Now!
HLI - Cash & Debt
14-Day FREE Trial Get Full Access Now!
HLI - Revenue
14-Day FREE Trial Get Full Access Now!
HLI Revenue CAGR:1Y: 24.12%2Y: 17.89%5Y: 13.72%10Y: 12.43%
HLI - Earnings Per Share (EPS)
14-Day FREE Trial Get Full Access Now!
HLI EPS CAGR:1Y: 33.65%2Y: 24.28%5Y: 13.13%10Y: 13.26%
HLI - Net Income
14-Day FREE Trial Get Full Access Now!
HLI Net Income CAGR:1Y: 34.60%2Y: 22.94%5Y: 14.28%10Y: 14.71%
HLI - EBITDA
14-Day FREE Trial Get Full Access Now!
HLI EBITDA CAGR:1Y: 53.55%2Y: 27.53%5Y: 16.98%10Y: 14.85%
HLI - Free Cash Flow
14-Day FREE Trial Get Full Access Now!
HLI Free Cash Flow CAGR:1Y: 206.70%2Y: 84.11%5Y: 22.48%10Y: 9.61%
HLI - Free Cash Flow / Share
14-Day FREE Trial Get Full Access Now!
HLI Free Cash Flow / Share CAGR:1Y: 200.09%2Y: 80.65%5Y: 21.03%10Y: 8.67%
HLI - Gross Profit
14-Day FREE Trial Get Full Access Now!
HLI Gross Profit CAGR:1Y: 9.07%2Y: 10.49%5Y: 11.13%10Y: 13.43%
HLI - Expenses
14-Day FREE Trial Get Full Access Now!
HLI Expenses CAGR:1Y: -75.29%2Y: -47.28%5Y: 7.43%10Y: 11.53%
HLI - Shares Outstanding
14-Day FREE Trial Get Full Access Now!
HLI Shares Outstanding CAGR:1Y: 1.29%2Y: -0.69%5Y: 0.94%10Y: 1.29%
HLI - Share Buybacks
14-Day FREE Trial Get Full Access Now!
HLI Share Buybacks CAGR:1Y: -9.47%2Y: -32.00%5Y: -54.32%10Y: 0.00%
HLI - Stock-Based Comp
14-Day FREE Trial Get Full Access Now!
HLI Stock-Based Comp CAGR:1Y: 3.67%2Y: 5.75%5Y: 22.27%10Y: 21.73%
HLI - Dividends
14-Day FREE Trial Get Full Access Now!
HLI Dividend CAGR:1Y: 3.64%2Y: 3.70%5Y: 12.95%10Y: N/A
HLI - Revenue by Segment
14-Day FREE Trial Get Full Access Now!
HLI Revenue CAGR:1Y: 24.12%2Y: 17.89%5Y: 13.72%10Y: 12.43%

Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:

HLI - REVENUE: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
HLI Actual Revenue CAGR:1Y: 24.12%2Y: 17.89%5Y: 13.72%10Y: 12.43%
HLI - EPS: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
HLI Actual EPS CAGR:1Y: 33.65%2Y: 24.28%5Y: 13.13%10Y: 13.26%
HLI - NET INCOME: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
HLI Actual Net Income CAGR:1Y: 34.60%2Y: 22.94%5Y: 14.28%10Y: 14.71%
HLI - EBITDA: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
HLI Actual EBITDA CAGR:1Y: 53.55%2Y: 27.53%5Y: 16.98%10Y: 14.85%

Ratios, Profit Margins & Return on Capital:

HLI - Net Profit Margin
14-Day FREE Trial Get Full Access Now!
HLI Net Profit Margin CAGR:1Y: 8.45%2Y: 4.29%5Y: 0.49%10Y: 2.03%
HLI - Gross Profit Margin
14-Day FREE Trial Get Full Access Now!
HLI Gross Profit Margin CAGR:1Y: -12.13%2Y: -6.29%5Y: -2.28%10Y: 0.89%
HLI - Price to Earnings
14-Day FREE Trial Get Full Access Now!
HLI - Price To Sales Ratio
14-Day FREE Trial Get Full Access Now!
HLI - Return on Capital Employed
14-Day FREE Trial Get Full Access Now!
HLI - Return on Invested Capital
14-Day FREE Trial Get Full Access Now!

Compare stocks side-by-side
 

HLI Dividends Info:

Annual Dividend: $2.28
Forward Yield: 1.37%
Ex-Dividend Date: 2025-03-03
Lifetime Dividens / Share: $13.75

HLI Dividend History: Dates, Payments & Yield list

Below is a schedule of all HLI dividend payments, ex-dates, share price on the day of the payment as well as TTM & forward yield

Ex-Date Payment Date Amount TTM Yield Forward Yield Price on Ex-Date
03/03/202503/17/2025$0.5701.35%1.35%$169.15
12/02/202412/16/2024$0.5701.21%1.22%$186.97
09/03/202409/16/2024$0.5701.48%1.51%$151.45
06/03/202406/17/2024$0.5701.66%1.7%$133.83
02/29/202403/15/2024$0.5501.71%1.71%$128.66
11/30/202312/15/2023$0.5502.02%2.04%$107.72
08/31/202309/15/2023$0.5502.05%2.09%$105.34
06/01/202306/15/2023$0.5502.44%2.51%$87.61
03/01/202303/15/2023$0.5302.23%2.23%$95.20
12/01/202212/15/2022$0.5302.04%2.14%$99.09
09/01/202209/15/2022$0.5302.47%2.73%$77.75
06/01/202206/15/2022$0.5302.17%2.53%$83.76
03/01/202203/15/2022$0.4301.72%1.72%$99.75
12/01/202112/15/2021$0.4301.53%1.63%$105.70
09/01/202109/15/2021$0.4301.68%1.9%$90.38
06/01/202106/15/2021$0.4301.9%2.3%$74.75
03/01/202103/15/2021$0.3302%2.03%$65.08
12/01/202012/15/2020$0.3301.94%2%$65.92
09/01/202009/15/2020$0.3302.13%2.23%$59.16
06/04/202006/15/2020$0.3102.06%2.06%$60.15
03/04/202003/16/2020$0.3102.35%2.35%$52.87
12/04/201912/16/2019$0.3102.5%2.59%$47.93
09/04/201909/16/2019$0.3102.64%2.82%$43.95
05/31/201906/14/2019$0.3102.48%2.74%$45.21
03/01/201903/15/2019$0.2702.31%2.31%$46.75
11/30/201812/14/2018$0.2700%0%$0.00
08/30/201809/17/2018$0.2700%0%$0.00
06/01/201806/15/2018$0.2700%0%$0.00
03/01/201803/15/2018$0.2000%0%$0.00
12/01/201712/15/2017$0.2000%0%$0.00
08/30/201709/15/2017$0.2000%0%$0.00
05/31/201706/15/2017$0.2000%0%$0.00
03/01/201703/15/2017$0.2000%0%$0.00
12/01/201612/15/2016$0.1700%0%$0.00
08/31/201609/15/2016$0.1700%0%$0.00
06/01/201606/15/2016$0.1700%0%$0.00
03/02/201603/15/2016$0.1500%0%$0.00
12/02/201512/15/2015$0.1500%0%$0.00

Projected Future Returns & Dividends for HLI

Based on past 6.3-year performance, here are HLI growth metrics:

Share price CAGR of +23.11%
Dividend CAGR of +15.52%

Using HLI CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:

HLI (DRIP)HLI - No DRIP
Current Price$163.90$163.90
Start Shares61.0161.01
Start Value$10,000$10,000
  
After 10 years:
Final Share Count67.8461.01
Dividends Payment$2.41$2.41
Annual Dividends$655$589
Yield on cost6.55%5.89%
Share Price$1,064.38$1,064.38
Total Dividends$3,106$2,897
Final Value$72,209$67,838

Estimated Future Value + Dividends - HLI

NOTE: Above numbers are our estimate based on HLI's Dividend and Price CAGR over past 6.3 years. These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.

We cannot guarantee that your actual returns will meet these estimates.

Get the best Dividend Stock Research Tools:

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 25% OFF
$135/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial

Company Info

Houlihan Lokey, Inc. (HLI) had its IPO on 2015-08-13, and is trader on NYSE stock exchange.

Houlihan Lokey, Inc., an investment banking company, provides merger and acquisition (M&A), capital market, financial restructuring, and financial and valuation advisory services worldwide. It operates in three segments: Corporate Finance, Financial Restructuring, and Financial and Valuation Advisory. The Corporate Finance segment offers general financial advisory services; and advises public and private institutions on buy-side and sell-side transactions, leveraged loans, private mezzanine debt, high-yield debt, initial public offerings, follow-ons, convertibles, equity private placements, private equity, and liability management transactions, as well as advise financial sponsors on various transactions. The Financial Restructuring segment advises debtors, creditors, and other parties-in-interest related to recapitalization/deleveraging transactions. It also provides a range of advisory services, including structuring, negotiation, and confirmation of plans of reorganization; structuring and analysis of exchange offers; corporate viability assessment; dispute resolution and expert testimony; and procuring debtor-in-possession financing. The Financial and Valuation Advisory segment offers valuations of various assets, such as companies, illiquid debt and equity securities, and intellectual property. It also provides fairness opinions in connection with M&A and other transactions, and solvency opinions in connection with corporate spin-offs and dividend recapitalizations; and other types of financial opinions. In addition, this segment offers dispute resolution services. It serves corporations, institutions, and governments. The company was incorporated in 1972 and is headquartered in Los Angeles, California with offices in the United States, Europe, the Middle East, and the Asia-Pacific region.

HLI website: https://www.hl.com


Get Full Access to All Reports with DRIPCalc PRO

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 25% OFF
$135/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial